Search for: "Cornerstone Pharmaceuticals, Inc." Results 1 - 20 of 29
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jul 2013, 8:52 pm by Patent Docs
Cornerstone Therapeutics Inc. et al. v. [read post]
23 Apr 2007, 11:14 am
Breckenridge Pharmaceutical, Inc. v. [read post]
11 Aug 2013, 7:45 pm by Patent Docs
EKR Therapeutics, LLC et al. 5:13-cv-00111; filed August 8, 2013 in the Western District of North Carolina • Plaintiff: Exela Pharma Sciences, LLC • Defendants: EKR Therapeutics, LLC; Cornerstone Therapeutics Inc.; Cornerstone BioPharma, Inc. [read post]
12 Feb 2015, 5:02 am by Mary Jane Wilmoth
The Department of Justice (DOJ) announced on January 9, 2015, that Daiichi Sankyo Inc., a global pharmaceutical company with its U.S. headquarters in New Jersey, agreed to pay the United States and state Medicaid programs $39 million to resolve allegations that it violated the False Claims Act. [read post]
17 Jun 2009, 5:27 am
According to the Food and Drug Administration, drugs including Singulair, AstraZeneca Plc’s Accolate and Cornerstone Therapeutics Inc’s Zyflo and Zyflo CR may cause agitation, aggression, suicidal thinking, suicide, depression, insomnia and irritability. [read post]
16 Dec 2010, 8:48 am by etoupin
Cornerstone Pharmaceuticals, Inc., is another company to receive funding through QTDP for cancer treatment research. [read post]
3 Mar 2020, 4:00 am by Alan Macek
In Novartis Pharmaceuticals Canada Inc. v. [read post]
11 Aug 2020, 6:30 am by Rebecca Shafer, J.D.
   Purpose of Training Training is the cornerstone of formal employee communication. [read post]
11 Feb 2018, 2:35 pm by Kevin LaCroix
  Synergy is not only a life sciences company but it is in SIC Code 2834 (Pharmaceutical Preparations). [read post]
13 Apr 2015, 4:22 am by Kevin LaCroix
PwC’s report is generally consistent with the reports previously published by Cornerstone Research and NERA. [read post]
13 May 2013, 8:35 am by Senior Editor
    Purpose of Training   Training is the cornerstone of formal employee communication. [read post]
18 Aug 2008, 12:07 pm
The district court dismissed the class action with prejudice on the ground that plaintiffs “failed to adequately plead loss causation” under Dura Pharmaceuticals, Inc.. v. [read post]
11 Oct 2018, 12:57 am by Eszter Szakács
The court examined the description in detail and highlighted that it unambiguously describes a pharmaceutical composition that contains the combination of ezetimibe and a cholesterol biosynthesis inhibitor. [read post]
24 May 2010, 11:18 am by @ErikJHeels
(Seekonk, MA) African Pharmaceutical Development And Manufacturing Initiative, Inc. [read post]